Kymera Therapeutics, Inc.盘中异动早盘快速下跌5.20%报33.38美元

自选股智能写手04-25

北京时间2024年04月25日21时41分，Kymera Therapeutics, Inc.（KYMR.us）股票出现异动，股价急速下挫5.20%。截至发稿，该股报33.38美元/股，成交量1.2235万股，换手率0.02%，振幅2.02%。最近的财报数据显示，该股实现营业收入78.59百万美元，净利润-1.47亿美元，每股收益-2.52美元，毛利75.03百万美元，市盈率-13.32倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2430028997?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-25 21:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2430028997","market":"us","top_or_hot":-1,"title":"Kymera Therapeutics, Inc.盘中异动 早盘快速下跌5.20%报33.38美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月25日21时41分，Kymera Therapeutics, Inc.（KYMR.us）股票出现异动，股价急速下挫5.20%。截至发稿，该股报33.38美元/股，成交量1.2235万股，换手率0.02%，振幅2.02%。最近的财报数据显示，该股实现营业收入78.59百万美元，净利润-1.47亿美元，每股收益-2.52美元，毛利75.03百万美元，市盈率-13.32倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kymera Therapeutics, Inc.盘中异动 早盘快速下跌5.20%报33.38美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKymera Therapeutics, Inc.盘中异动 早盘快速下跌5.20%报33.38美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-25 21:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月25日21时41分，Kymera Therapeutics, Inc.（KYMR.us）股票出现异动，股价急速下挫5.20%。截至发稿，该股报33.38美元/股，成交量1.2235万股，换手率0.02%，振幅2.02%。最近的财报数据显示，该股实现营业收入78.59百万美元，净利润-1.47亿美元，每股收益-2.52美元，毛利75.03百万美元，市盈率-13.32倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b","article_id":"2430028997","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2430028997","pubTimestamp":1714052481,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月25日21时41分，Kymera Therapeutics, Inc.股票出现异动，股价急速下挫5.20%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。该信息摘要如下：Kymera Therapeutics获奥本海默首次覆盖，给予优于大市评级, 目标价53.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","KYMR":"Kymera Therapeutics, Inc.","LENZ":"Therapeutics"},"translate_title":"Kymera Therapeutics, Inc. fell 5.20% to $33.38 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KYMR":1,"LENZ":1},"content_text":"北京时间2024年04月25日21时41分，Kymera Therapeutics, Inc.（KYMR.us）股票出现异动，股价急速下挫5.20%。截至发稿，该股报33.38美元/股，成交量1.2235万股，换手率0.02%，振幅2.02%。最近的财报数据显示，该股实现营业收入78.59百万美元，净利润-1.47亿美元，每股收益-2.52美元，毛利75.03百万美元，市盈率-13.32倍。机构评级方面，在所有17家参与评级的机构中，65%的券商给予买入建议，35%的券商给予持有建议，无券商给予卖出建议。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 (To Pur Com)、Zura Bio Limited C/Wts (To Pur Com)涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为1023.27%、187.71%、7.40%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024(To Pur Com)、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为40.85%、25.31%、14.75%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。 该公司正在推进有针对性的蛋白质降解领域，利用人体固有的蛋白质回收机制来降解失调的致病蛋白质。 Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。 它以无与伦比的靶向和降解难治蛋白质的能力，加速了药物研发，并为患者提供了新的治疗选择。消息层面，截至21时41分，《Kymera Therapeutics(KYMR.US)获奥本海默首次覆盖，给予优于大市评级, 目标价53.00美元。》资讯为影响Kymera Therapeutics, Inc.的重要信息。该信息摘要如下：Kymera Therapeutics(KYMR.US)获奥本海默首次覆盖，给予优于大市评级, 目标价53.00美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2430028997"}

Kymera Therapeutics, Inc.盘中异动 早盘快速下跌5.20%报33.38美元

精彩评论

Kymera Therapeutics, Inc.盘中异动早盘快速下跌5.20%报33.38美元